The shares of a Hyderabad-based pharmaceutical company have given a return of more than 15% in the past year and global brokerage Nomura believes the stock has steam to rally another 17%.
The shares of a Hyderabad-based pharmaceutical company have given a return of more than 15% in the past year and global brokerage Nomura believes the stock has steam to rally another 17%.